Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycemic Profiles of Vildagliptin vs Sitagliptin in Insulin-Treated T2DM with CV Disease
NCT01686932Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Nov 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01686932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686932.